Morgane Baron

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Bart Staels, A. Rubenstrunk, Benoît Noël et al. · Hepatology · 2013 · 402 citations

Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPARγ and LXRα Pathways

Giulia Chinetti, Morgane Baron, Mohamed Amine Bouhlel et al. · Circulation Research · 2011 · 367 citations · Full text

Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension

Morgane Baron, Julie O’Sullivan Maillet, Marlène Huyvaert et al. · Nature Medicine · 2019 · 91 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Disorder +11

Peroxisome Proliferator–Activated Receptor-α Gene Level Differently Affects Lipid Metabolism and Inflammation in Apolipoprotein E2 Knock-In Mice

Fanny Lalloyer, Kristiaan Wouters, Morgane Baron et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 71 citations · Full text

Activation of intestinal peroxisome proliferator-activated receptor-  increases high-density lipoprotein production

S. Colin, Olivier Briand, Véronique Touche et al. · European Heart Journal · 2012 · 62 citations · Full text